marketcaparena

ZBH

ZIMMER BIOMET HOLDINGS, INC.

Company overview

Market capitalization
$17.48B
Employees
17,000
Latest publication
2026-09-29
About ZIMMER BIOMET HOLDINGS, INC.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Revenue2,177,000,000USD2,086,700,000USD2,243,800,000USD2,001,400,000USD2,077,300,000USD1,909,100,000USD2,023,200,000USD1,824,200,000USD
Cost Of Revenue635,500,000USD576,200,000USD—559,300,000USD592,200,000USD549,800,000USD586,700,000USD538,600,000USD
Gross Profit1,541,500,000USD1,510,500,000USD1,273,700,000USD1,442,100,000USD1,485,100,000USD1,359,300,000USD1,436,500,000USD1,285,600,000USD
Research Development104,800,000USD103,400,000USD118,800,000USD115,900,000USD113,300,000USD110,600,000USD108,500,000USD111,600,000USD
Selling General Administrative899,300,000USD849,900,000USD872,300,000USD811,400,000USD814,800,000USD758,800,000USD746,900,000USD709,700,000USD
Total Operating Expenses1,215,400,000USD1,137,300,000USD—1,090,800,000USD1,185,100,000USD1,067,000,000USD1,047,500,000USD1,006,100,000USD
Operating Income326,100,000USD373,200,000USD154,500,000USD351,300,000USD300,000,000USD292,300,000USD389,000,000USD279,500,000USD
Total Other Income Expense Net-71,000,000USD-71,900,000USD—-72,100,000USD-75,400,000USD-63,300,000USD-100,000,000USD-49,200,000USD
Net Interest Income-72,900,000USD-68,800,000USD—-75,400,000USD-79,300,000USD-66,200,000USD-61,900,000USD-54,300,000USD
Litigation Settlement Expense17,800,000USD5,000,000USD—3,100,000USD————
Income Before Tax255,100,000USD301,300,000USD98,000,000USD279,200,000USD224,600,000USD229,000,000USD289,000,000USD230,300,000USD
Income Tax Expense55,500,000USD63,000,000USD39,900,000USD48,000,000USD71,200,000USD46,500,000USD48,900,000USD-18,900,000USD
Net Income199,600,000USD238,300,000USD137,900,000USD231,200,000USD152,800,000USD182,000,000USD239,500,000USD249,100,000USD
Minority Interest1,300,000USD200,000USD—300,000USD-600,000USD-600,000USD-700,000USD-200,000USD
Net Income Applicable To Common Shares198,300,000USD238,100,000USD—230,900,000USD152,800,000USD182,000,000USD239,500,000USD249,100,000USD
Unclassified Operating Expenses————257,000,000USD197,600,000USD192,100,000USD184,800,000USD
Interest Income————79,300,000USD66,200,000USD61,900,000USD54,300,000USD
Interest Expense————79,300,000USD66,200,000USD61,900,000USD54,300,000USD
Tax Provision————71,200,000USD46,500,000USD48,900,000USD-18,900,000USD
Net Income From Continuing Ops————153,400,000USD182,600,000USD240,100,000USD249,200,000USD
Ebit————303,900,000USD295,200,000USD350,900,000USD284,600,000USD
Ebitda————575,700,000USD549,600,000USD614,500,000USD535,500,000USD
Depreciation And Amortization————271,800,000USD254,400,000USD263,600,000USD250,900,000USD
Reconciled Depreciation————271,800,000USD254,400,000USD263,600,000USD250,900,000USD
SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosurePreliminaryDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USD
Total Revenue8,231,500,000USD7,678,600,000USD7,394,200,000USD6,939,900,000USD6,827,300,000USD7,932,900,000USD7,803,300,000USD7,668,400,000USD
Cost Of Revenue2,493,700,000USD2,191,200,000USD2,083,800,000USD2,019,500,000USD1,960,400,000USD2,271,900,000USD2,132,900,000USD2,381,800,000USD
Gross Profit5,737,800,000USD5,487,400,000USD5,310,400,000USD4,920,400,000USD4,866,900,000USD5,661,000,000USD5,670,400,000USD5,286,600,000USD
Research Development458,500,000USD437,400,000USD458,700,000USD406,000,000USD435,800,000USD391,700,000USD369,900,000USD365,600,000USD
Selling General Administrative3,257,200,000USD2,929,800,000USD2,843,700,000USD2,761,700,000USD3,323,900,000USD3,379,300,000USD3,369,700,000USD2,944,600,000USD
Total Operating Expenses4,639,700,000USD4,201,700,000USD4,032,700,000USD4,224,100,000USD4,006,600,000USD5,627,200,000USD4,871,100,000USD4,465,500,000USD
Operating Income1,098,100,000USD1,285,700,000USD1,277,700,000USD696,300,000USD860,300,000USD33,800,000USD799,300,000USD821,100,000USD
Total Other Income Expense Net-267,300,000USD-249,100,000USD-210,400,000USD-292,800,000USD-361,300,000USD-304,900,000USD-334,700,000USD-421,500,000USD
Net Interest Income-292,800,000USD-218,000,000USD-193,500,000USD-164,800,000USD-208,400,000USD-289,300,000USD-325,300,000USD-355,000,000USD
Litigation Settlement Expense22,700,000USD———————
Income Before Tax830,800,000USD1,036,600,000USD1,067,300,000USD403,500,000USD499,000,000USD-271,100,000USD464,600,000USD399,600,000USD
Income Tax Expense125,700,000USD131,400,000USD42,200,000USD112,300,000USD53,500,000USD108,200,000USD-1,348,800,000USD95,000,000USD
Net Income705,100,000USD903,800,000USD1,024,000,000USD231,400,000USD401,600,000USD-379,200,000USD1,813,800,000USD305,900,000USD
Minority Interest-100,000USD-1,500,000USD-900,000USD-1,000,000USD-500,000USD-100,000USD-400,000USD-1,300,000USD
Unclassified Operating Expenses—834,500,000USD730,300,000USD1,056,400,000USD246,900,000USD1,856,200,000USD866,500,000USD1,155,300,000USD
Interest Income—218,000,000USD201,200,000USD164,800,000USD208,400,000USD3,300,000USD2,200,000USD2,900,000USD
Interest Expense—218,000,000USD201,200,000USD164,800,000USD208,400,000USD289,300,000USD325,300,000USD355,000,000USD
Tax Provision—131,400,000USD232,800,000USD112,300,000USD16,300,000USD108,200,000USD-1,348,800,000USD95,000,000USD
Net Income From Continuing Ops—905,200,000USD475,200,000USD291,200,000USD402,100,000USD-379,300,000USD1,813,400,000USD304,600,000USD
Ebit—1,254,600,000USD1,268,500,000USD568,300,000USD707,400,000USD18,200,000USD789,900,000USD754,600,000USD
Ebitda—2,250,900,000USD2,220,200,000USD1,494,700,000USD1,645,100,000USD1,058,700,000USD1,852,600,000USD1,793,900,000USD
Depreciation And Amortization—996,300,000USD951,700,000USD926,400,000USD937,700,000USD1,040,500,000USD1,062,700,000USD1,039,300,000USD
Reconciled Depreciation—996,300,000USD939,000,000USD926,400,000USD1,067,400,000USD1,040,500,000USD1,062,700,000USD—
Net Income Applicable To Common Shares—903,800,000USD1,024,000,000USD231,400,000USD401,600,000USD-379,200,000USD1,813,800,000USD305,900,000USD
Non Operating Income Net Other———-128,000,000USD-153,300,000USD-15,600,000USD-16,100,000USD-68,400,000USD
Discontinued Operations———-58,800,000USD-43,400,000USD———
Selling And Marketing Expenses——————265,000,000USD—
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets22,797,800,000USD22,721,600,000USD23,091,700,000USD23,488,000,000USD22,865,100,000USD22,183,900,000USD21,365,300,000USD21,720,300,000USD
Cash And Equivalents410,000,000USD424,200,000USD591,900,000USD1,292,700,000USD556,900,000USD1,384,500,000USD525,500,000USD569,000,000USD
Total Current Assets5,096,700,000USD4,962,500,000USD5,119,900,000USD5,834,900,000USD5,053,900,000USD5,590,200,000USD4,671,500,000USD4,864,000,000USD
Other Current Assets646,900,000USD562,900,000USD537,300,000USD460,300,000USD431,500,000USD428,100,000USD430,000,000USD444,800,000USD
Other Non Current Assets1,083,300,000USD1,067,900,000USD1,100,300,000USD1,017,200,000USD————
Total Liabilities10,165,300,000USD10,040,000,000USD10,386,000,000USD10,722,000,000USD————
Total Current Liabilities3,013,500,000USD2,864,300,000USD2,583,700,000USD2,402,900,000USD2,699,500,000USD2,294,900,000USD2,450,900,000USD3,571,300,000USD
Other Current Liabilities1,125,300,000USD1,033,300,000USD1,693,600,000USD1,487,600,000USD————
Other Non Current Liabilities638,700,000USD630,700,000USD626,100,000USD806,400,000USD————
Total Stockholder Equity12,623,900,000USD12,673,300,000USD12,697,700,000USD12,756,500,000USD12,525,000,000USD12,395,100,000USD12,468,100,000USD12,374,700,000USD
Total Equity Including Noncontrolling Interest12,632,500,000USD12,681,600,000USD12,705,800,000USD12,766,000,000USD————
Short Long Term Debt2,403,000,000USD2,351,800,000USD1,174,200,000USD1,200,000,000USD820,000,000USD600,000,000USD863,000,000USD1,713,000,000USD
Long Term Debt6,277,500,000USD6,295,100,000USD6,932,000,000USD7,512,600,000USD6,752,500,000USD6,576,300,000USD5,341,600,000USD4,859,500,000USD
Net Receivables1,769,500,000USD1,728,600,000USD1,704,400,000USD1,598,300,000USD1,611,300,000USD1,533,400,000USD1,480,700,000USD1,481,500,000USD
Inventory2,270,300,000USD2,246,800,000USD2,286,400,000USD2,483,700,000USD2,454,200,000USD2,244,200,000USD2,235,300,000USD2,368,700,000USD
Property Plant Equipment Net2,236,800,000USD2,211,700,000USD2,411,300,000USD2,194,300,000USD2,175,700,000USD2,064,900,000USD2,048,800,000USD2,107,200,000USD
Goodwill9,919,500,000USD9,931,800,000USD9,947,100,000USD9,702,000,000USD————
Intangible Assets4,461,600,000USD4,547,600,000USD4,717,300,000USD4,739,700,000USD4,890,800,000USD4,468,000,000USD4,598,400,000USD4,665,300,000USD
Accounts Payable352,400,000USD361,200,000USD303,000,000USD315,300,000USD348,700,000USD301,300,000USD194,600,000USD322,400,000USD
Common Stock3,200,000USD3,200,000USD3,200,000USD3,200,000USD3,200,000USD3,200,000USD3,200,000USD3,200,000USD
Retained Earnings11,955,100,000USD11,802,500,000USD11,611,000,000USD11,518,600,000USD11,335,200,000USD11,229,700,000USD11,095,300,000USD10,903,700,000USD
Accumulated Other Comprehensive Income-163,900,000USD-190,400,000USD-205,700,000USD-283,800,000USD-284,500,000USD-287,300,000USD-262,800,000USD-202,200,000USD
Short Term Debt——57,500,000USD—820,000,000USD600,000,000USD863,000,000USD1,713,000,000USD
Total Liab————10,330,800,000USD9,780,100,000USD8,889,100,000USD9,337,100,000USD
Other Current Liab————1,530,800,000USD1,393,600,000USD1,393,300,000USD1,535,900,000USD
Capital Stock————3,200,000USD3,200,000USD3,200,000USD3,200,000USD
Good Will————9,709,500,000USD8,988,600,000USD8,951,100,000USD8,912,300,000USD
Other Assets————1,035,200,000USD100,000USD1,095,500,000USD-100,000USD
Cash————556,900,000USD1,384,500,000USD525,500,000USD569,000,000USD
Cash And Short Term Investments————556,900,000USD1,384,500,000USD525,500,000USD569,000,000USD
Net Debt————7,015,600,000USD5,791,800,000USD5,679,100,000USD5,881,700,000USD
Short Long Term Debt Total————7,572,500,000USD7,176,300,000USD6,204,600,000USD6,450,700,000USD
Property Plant Equipment Gross————7,145,500,000USD6,823,400,000USD6,690,200,000USD6,896,100,000USD
Common Stock Shares Outstanding————198,300,000shares199,700,000shares199,900,000shares203,000,000shares
Non Current Assets Total————17,811,200,000USD16,593,600,000USD16,693,800,000USD16,856,400,000USD
Non Current Liabilities Total————7,631,300,000USD7,485,200,000USD6,438,200,000USD5,765,800,000USD
Non Current Liabilities Other————878,800,000USD908,900,000USD744,100,000USD1,028,100,000USD
Non Currrent Assets Other————1,003,000,000USD982,000,000USD1,022,300,000USD1,107,200,000USD
Net Working Capital————2,354,400,000USD3,295,300,000USD2,220,600,000USD1,292,700,000USD
Unclassified Non Current Assets————-1,003,000,000USD—-1,022,300,000USD—
Unclassified Current Liabilities————-820,000,000USD-600,000,000USD-863,000,000USD-1,713,000,000USD
Unclassified Equity————1,467,900,000USD1,446,300,000USD1,629,200,000USD1,666,800,000USD
Unclassified Non Current Liabilities——————352,500,000USD-121,800,000USD
Current Deferred Revenue———————-322,400,000USD
SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets23,091,700,000USD21,365,300,000USD21,496,900,000USD21,066,000,000USD23,456,400,000USD24,417,700,000USD24,638,700,000USD24,126,800,000USD
Cash And Equivalents591,900,000USD525,500,000USD415,800,000USD375,700,000USD478,500,000USD802,100,000USD617,900,000USD542,800,000USD
Total Current Assets5,119,900,000USD4,671,500,000USD4,609,500,000USD4,427,300,000USD4,885,000,000USD5,083,300,000USD4,723,900,000USD4,427,400,000USD
Other Current Assets537,300,000USD430,000,000USD366,100,000USD522,900,000USD1,099,300,000USD377,800,000USD357,100,000USD352,300,000USD
Other Non Current Assets1,100,300,000USD———————
Total Liabilities10,386,000,000USD———————
Total Current Liabilities2,583,700,000USD2,450,900,000USD2,857,400,000USD2,358,200,000USD3,467,900,000USD2,556,900,000USD3,441,500,000USD2,421,300,000USD
Other Current Liabilities1,693,600,000USD———————
Other Non Current Liabilities626,100,000USD———————
Total Stockholder Equity12,697,700,000USD12,468,100,000USD12,480,500,000USD12,020,300,000USD12,660,700,000USD12,194,200,000USD12,388,100,000USD11,271,300,000USD
Total Equity Including Noncontrolling Interest12,705,800,000USD———————
Short Long Term Debt1,174,200,000USD863,000,000USD900,000,000USD544,300,000USD1,605,100,000USD500,000,000USD1,500,000,000USD525,000,000USD
Long Term Debt6,932,000,000USD5,341,600,000USD5,012,600,000USD5,152,200,000USD5,463,700,000USD7,626,500,000USD6,721,400,000USD8,413,700,000USD
Net Receivables1,704,400,000USD1,480,700,000USD1,442,400,000USD1,381,500,000USD1,259,600,000USD1,452,700,000USD1,363,900,000USD1,275,800,000USD
Inventory2,286,400,000USD2,235,300,000USD2,385,200,000USD2,147,200,000USD2,148,000,000USD2,450,700,000USD2,385,000,000USD2,256,500,000USD
Property Plant Equipment Net2,411,300,000USD2,048,800,000USD2,060,400,000USD1,872,500,000USD1,836,600,000USD2,047,700,000USD2,077,400,000USD2,015,400,000USD
Goodwill9,947,100,000USD———————
Intangible Assets4,717,300,000USD4,598,400,000USD4,856,400,000USD5,063,800,000USD5,533,600,000USD7,055,500,000USD7,257,600,000USD7,684,600,000USD
Accounts Payable303,000,000USD194,600,000USD410,600,000USD354,100,000USD306,500,000USD330,000,000USD400,900,000USD362,600,000USD
Short Term Debt57,500,000USD863,000,000USD900,000,000USD544,300,000USD1,605,100,000USD500,000,000USD1,500,000,000USD525,000,000USD
Common Stock3,200,000USD3,200,000USD3,200,000USD3,100,000USD3,100,000USD3,100,000USD3,100,000USD3,100,000USD
Retained Earnings11,611,000,000USD11,095,300,000USD10,384,500,000USD9,559,300,000USD10,292,200,000USD10,086,900,000USD10,427,300,000USD9,491,200,000USD
Accumulated Other Comprehensive Income-205,700,000USD-262,800,000USD-191,000,000USD-179,300,000USD-231,600,000USD-297,800,000USD-241,900,000USD-187,400,000USD
Total Liab—8,889,100,000USD9,008,800,000USD9,039,000,000USD10,790,000,000USD12,218,300,000USD12,245,900,000USD12,850,700,000USD
Other Current Liab—1,393,300,000USD1,485,600,000USD1,421,300,000USD1,494,300,000USD1,522,400,000USD1,413,900,000USD1,391,300,000USD
Capital Stock—3,200,000USD3,200,000USD3,100,000USD3,100,000USD3,100,000USD3,100,000USD3,100,000USD
Good Will—8,951,100,000USD8,818,500,000USD8,580,200,000USD8,919,400,000USD9,261,800,000USD9,599,700,000USD9,594,400,000USD
Other Assets—882,000,000USD948,300,000USD1,122,200,000USD1,062,900,000USD969,400,000USD652,900,000USD387,100,000USD
Cash—525,500,000USD415,800,000USD375,700,000USD378,100,000USD802,100,000USD617,900,000USD542,800,000USD
Cash And Short Term Investments—525,500,000USD415,800,000USD375,700,000USD378,100,000USD802,100,000USD617,900,000USD542,800,000USD
Net Debt—5,679,100,000USD5,352,100,000USD5,320,800,000USD6,690,700,000USD7,324,400,000USD7,603,500,000USD8,395,900,000USD
Short Long Term Debt Total—6,204,600,000USD5,767,900,000USD5,696,500,000USD7,068,800,000USD8,126,500,000USD8,221,400,000USD8,938,700,000USD
Property Plant Equipment Gross—6,690,200,000USD6,766,200,000USD6,458,400,000USD6,137,700,000USD2,047,700,000USD2,077,400,000USD2,015,400,000USD
Common Stock Shares Outstanding—203,900,000shares209,700,000shares210,300,000shares210,400,000shares207,000,000shares206,700,000shares203,500,000shares
Non Current Assets Total—16,693,800,000USD16,887,400,000USD16,638,700,000USD18,571,400,000USD19,334,400,000USD19,914,800,000USD19,699,400,000USD
Non Current Liabilities Total—6,438,200,000USD6,151,400,000USD6,680,800,000USD7,322,100,000USD9,661,400,000USD8,804,400,000USD10,429,400,000USD
Non Current Liabilities Other—744,100,000USD652,200,000USD1,528,600,000USD1,858,400,000USD1,244,500,000USD1,242,900,000USD1,016,200,000USD
Non Currrent Assets Other—1,022,300,000USD1,120,500,000USD1,105,600,000USD2,254,200,000USD969,400,000USD909,800,000USD366,200,000USD
Net Working Capital—2,220,600,000USD1,752,100,000USD2,069,100,000USD1,417,100,000USD2,526,400,000USD1,282,400,000USD2,006,100,000USD
Unclassified Non Current Assets—-808,800,000USD-916,700,000USD-1,105,600,000USD-1,035,300,000USD-969,400,000USD-643,100,000USD-366,200,000USD
Unclassified Current Liabilities—-863,000,000USD-838,800,000USD-980,600,000USD-2,588,400,000USD-440,500,000USD-1,373,300,000USD-382,600,000USD
Unclassified Non Current Liabilities—352,500,000USD486,600,000USD-1,617,800,000USD-2,524,000,000USD-2,034,900,000USD-1,867,500,000USD-2,013,200,000USD
Unclassified Equity—1,629,200,000USD2,280,600,000USD9,501,300,000USD9,311,700,000USD9,118,500,000USD8,917,000,000USD8,683,000,000USD
Current Deferred Revenue——-30,400,000USD474,800,000USD1,045,300,000USD145,000,000USD-400,900,000USD-362,600,000USD
Short Term Investments——26,200,000USD6,800,000USD16,300,000USD———
Deferred Long Term Liab———474,800,000USD665,600,000USD790,400,000USD840,100,000USD999,500,000USD
Other Liab———1,143,000,000USD1,858,400,000USD2,034,900,000USD1,867,500,000USD2,013,200,000USD
Treasury Stock———-6,867,200,000USD-6,717,800,000USD-6,719,600,000USD-6,720,500,000USD-6,721,700,000USD
Net Tangible Assets———-1,623,700,000USD-2,825,600,000USD-4,123,100,000USD-4,469,200,000USD-6,007,700,000USD
Long Term Investments——————60,500,000USD17,900,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Depreciation270,800,000USD270,000,000USD—809,800,000USD271,800,000USD254,400,000USD263,600,000USD250,900,000USD
Stock Based Compensation24,600,000USD24,200,000USD—66,100,000USD21,200,000USD19,600,000USD21,100,000USD24,500,000USD
Change To Inventory-30,500,000USD-20,900,000USD——-37,200,000USD-3,000,000USD87,900,000USD3,800,000USD
Change To Liabilities92,000,000USD-183,000,000USD——————
Change In Working Capital-11,200,000USD-211,300,000USD——-68,200,000USD-73,900,000USD29,100,000USD-128,800,000USD
Operating Cash Flow447,800,000USD359,400,000USD517,400,000USD418,700,000USD————
Capital Expenditures-54,200,000USD-36,300,000USD——-80,100,000USD-47,000,000USD-84,900,000USD-27,100,000USD
Other Investing Activities100,000USD6,200,000USD——————
Unclassified Investing Cash Flow-136,700,000USD-128,900,000USD——1,336,400,000USD49,700,000USD115,500,000USD49,300,000USD
Investing Cash Flow-190,800,000USD-159,000,000USD—-1,653,700,000USD————
Common Stock Issuance100,000USD12,300,000USD——————
Net Common Stock Issuance-250,700,000USD-250,100,000USD——————
Common Dividends Paid-46,500,000USD-46,900,000USD——————
Other Financing Activities-2,300,000USD-15,600,000USD——————
Unclassified Financing Cash Flow28,300,000USD-68,900,000USD——————
Financing Cash Flow-271,100,000USD-369,200,000USD——————
Effect Of Forex Changes On Cash0USD1,100,000USD——————
Change In Cash-14,200,000USD-167,700,000USD—767,200,000USD-827,600,000USD859,000,000USD-43,500,000USD148,900,000USD
End Cash Flow410,000,000USD424,200,000USD—1,292,700,000USD————
Net Income——137,900,000USD231,200,000USD153,400,000USD182,600,000USD240,100,000USD249,200,000USD
Other Non Cash Items————0USD100,000USD-47,600,000USD-100,000USD
Change To Account Receivables————200,000USD-18,800,000USD-49,600,000USD-29,900,000USD
Total Cash From Operating Activities————378,200,000USD382,800,000USD506,300,000USD395,700,000USD
Free Cash Flow————298,100,000USD335,800,000USD421,400,000USD368,600,000USD
Investments————-1,384,400,000USD-106,000,000USD-291,200,000USD-154,900,000USD
Total Cashflows From Investing Activities————-1,384,400,000USD-106,000,000USD-291,200,000USD-154,900,000USD
Net Borrowings————220,000,000USD885,100,000USD-113,700,000USD535,000,000USD
Total Cash From Financing Activities————163,800,000USD575,400,000USD-240,600,000USD-101,900,000USD
Dividends Paid————-47,500,000USD-47,800,000USD-48,000,000USD-49,200,000USD
Sale Purchase Of Stock————-7,200,000USD-229,800,000USD-72,200,000USD-596,300,000USD
Begin Period Cash Flow————1,384,500,000USD525,500,000USD569,000,000USD420,100,000USD
End Period Cash Flow————556,900,000USD1,384,500,000USD525,500,000USD569,000,000USD
Other Cashflows From Investing Activities————-1,256,300,000USD-2,700,000USD-30,600,000USD-22,200,000USD
Other Cashflows From Financing Activities————-1,500,000USD-32,100,000USD-6,700,000USD8,600,000USD
SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosurePreliminaryDisclosurePreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow YTD

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ3 20252025-09-30 · USD
Depreciation540,800,000USD809,800,000USD
Stock Based Compensation48,800,000USD66,100,000USD
Change To Inventory-51,400,000USD-86,200,000USD
Change To Liabilities-91,000,000USD-11,100,000USD
Change In Working Capital-222,500,000USD-272,000,000USD
Operating Cash Flow807,200,000USD1,179,700,000USD
Capital Expenditures-90,500,000USD-149,700,000USD
Other Investing Activities6,300,000USD3,800,000USD
Unclassified Investing Cash Flow-265,600,000USD-1,507,800,000USD
Investing Cash Flow-349,800,000USD-1,653,700,000USD
Common Stock Issuance12,400,000USD38,000,000USD
Net Common Stock Issuance-500,800,000USD-237,000,000USD
Common Dividends Paid-93,400,000USD-142,800,000USD
Other Financing Activities-17,900,000USD-16,600,000USD
Unclassified Financing Cash Flow-40,600,000USD1,581,400,000USD
Financing Cash Flow-640,300,000USD1,223,000,000USD
Effect Of Forex Changes On Cash1,100,000USD18,200,000USD
Change In Cash-181,900,000USD767,200,000USD
End Cash Flow410,000,000USD1,292,700,000USD
SourceDisclosureDeterministicFinalDisclosureDeterministicFinal

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USD
Depreciation1,093,800,000USD996,300,000USD951,700,000USD1,032,700,000USD1,006,100,000USD1,040,500,000USD1,062,700,000USD1,039,300,000USD
Stock Based Compensation90,200,000USD101,000,000USD99,800,000USD79,700,000USD84,300,000USD65,500,000USD53,700,000USD57,300,000USD
Deferred Income Tax-87,200,000USD———————
Change To Inventory98,200,000USD49,900,000USD-240,400,000USD-40,800,000USD-125,200,000USD-199,500,000USD-120,100,000USD77,900,000USD
Change To Liabilities101,800,000USD——-386,200,000USD69,400,000USD5,100,000USD2,000,000USD17,800,000USD
Change In Working Capital33,400,000USD-455,400,000USD-396,200,000USD-415,500,000USD-706,200,000USD27,600,000USD64,200,000USD-23,500,000USD
Operating Cash Flow1,697,100,000USD———————
Capital Expenditures-224,500,000USD-356,800,000USD-394,500,000USD-117,900,000USD-404,700,000USD-162,700,000USD-156,000,000USD-184,700,000USD
Other Investing Activities4,600,000USD———————
Unclassified Investing Cash Flow-1,755,800,000USD546,600,000USD360,800,000USD—197,600,000USD-291,600,000USD169,800,000USD-1,788,500,000USD
Investing Cash Flow-1,975,700,000USD———————
Common Stock Issuance39,700,000USD———————
Net Common Stock Issuance-487,000,000USD———————
Common Dividends Paid-190,300,000USD———————
Other Financing Activities-17,700,000USD———————
Unclassified Financing Cash Flow981,300,000USD——-1,604,600,000USD-907,400,000USD-107,900,000USD415,800,000USD-126,600,000USD
Financing Cash Flow326,000,000USD———————
Effect Of Forex Changes On Cash19,000,000USD———————
Change In Cash66,400,000USD109,700,000USD40,100,000USD184,200,000USD75,100,000USD18,400,000USD-109,700,000USD-825,200,000USD
End Cash Flow591,900,000USD———————
Net Income—905,200,000USD1,025,100,000USD-137,400,000USD1,131,500,000USD-379,300,000USD1,813,400,000USD304,600,000USD
Other Non Cash Items—-455,400,000USD-2,500,000USD633,000,000USD608,800,000USD979,700,000USD364,300,000USD407,700,000USD
Change To Account Receivables—-89,700,000USD-51,900,000USD-349,100,000USD-521,100,000USD213,600,000USD161,700,000USD-141,600,000USD
Total Cash From Operating Activities—1,499,400,000USD1,581,600,000USD1,204,500,000USD1,585,800,000USD1,747,400,000USD1,582,300,000USD1,632,200,000USD
Free Cash Flow—1,142,600,000USD1,187,100,000USD1,086,600,000USD1,181,100,000USD1,584,700,000USD1,426,300,000USD1,447,500,000USD
Investments—-888,100,000USD-670,600,000USD53,500,000USD48,100,000USD69,200,000USD-510,800,000USD284,700,000USD
Total Cashflows From Investing Activities—-888,100,000USD-778,900,000USD-613,800,000USD-729,300,000USD-416,600,000USD-510,800,000USD-1,691,500,000USD
Net Borrowings—536,300,000USD54,600,000USD-275,200,000USD-716,100,000USD-1,154,400,000USD-1,248,500,000USD-269,600,000USD
Total Cash From Financing Activities—-484,500,000USD-763,500,000USD-421,800,000USD-779,900,000USD-1,302,200,000USD-1,210,500,000USD-743,200,000USD
Dividends Paid—-196,000,000USD-200,900,000USD-198,500,000USD-196,700,000USD-195,200,000USD-193,600,000USD-188,400,000USD
Sale Purchase Of Stock—-868,000,000USD-692,200,000USD129,800,000USD158,200,000USD107,900,000USD-415,500,000USD-415,500,000USD
Begin Period Cash Flow—415,800,000USD375,700,000USD617,900,000USD542,800,000USD524,400,000USD634,100,000USD1,459,300,000USD
End Period Cash Flow—525,500,000USD415,800,000USD802,100,000USD617,900,000USD542,800,000USD524,400,000USD634,100,000USD
Other Cashflows From Investing Activities—-189,800,000USD-74,600,000USD-549,800,000USD-570,300,000USD-31,500,000USD-13,800,000USD-3,000,000USD
Other Cashflows From Financing Activities—43,200,000USD75,000,000USD1,526,700,000USD882,100,000USD47,400,000USD231,300,000USD256,900,000USD
Unclassified Operating Cash Flow—407,700,000USD-96,300,000USD—-538,700,000USD—-1,776,000,000USD-153,200,000USD
Cash And Cash Equivalents Changes———168,900,000USD76,600,000USD28,600,000USD-109,700,000USD-825,200,000USD
Exchange Rate Changes——————29,300,000USD-22,700,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q2 2026Quarterly · 2026-06-30GeographyAmericas1,359,000,000USDDisclosure
Q2 2026Quarterly · 2026-06-30GeographyAsia Pacific339,500,000USDDisclosure
Q2 2026Quarterly · 2026-06-30GeographyEMEA478,500,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductHips562,700,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductKnees828,900,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductSET586,000,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductTechnology And Data Bone Cement And Surgical199,400,000USDDisclosure
Q1 2026Quarterly · 2026-03-31GeographyAmericas1,324,500,000USDDisclosure
Q1 2026Quarterly · 2026-03-31GeographyAsia Pacific272,300,000USDDisclosure
Q1 2026Quarterly · 2026-03-31GeographyEMEA489,900,000USDDisclosure
Q1 2026Quarterly · 2026-03-31ProductHips524,100,000USDDisclosure
Q1 2026Quarterly · 2026-03-31ProductKnees828,600,000USDDisclosure
Q1 2026Quarterly · 2026-03-31ProductSET562,200,000USDDisclosure
Q1 2026Quarterly · 2026-03-31ProductTechnology And Data Bone Cement And Surgical171,800,000USDDisclosure
Q4 2025Quarterly · 2025-12-31GeographyAmericas1,410,400,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31GeographyAsia Pacific330,600,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31GeographyEMEA502,600,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductHips555,400,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductKnees911,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductSET587,600,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductTechnology And Data Bone Cement And Surgical189,800,000USDLegacy provider
FY 2025Yearly · 2025-12-31GeographyAmericas5,144,600,000USDDisclosure
FY 2025Yearly · 2025-12-31GeographyAsia Pacific1,258,100,000USDDisclosure
FY 2025Yearly · 2025-12-31GeographyEMEA1,828,800,000USDDisclosure
FY 2025Yearly · 2025-12-31ProductHips2,093,500,000USDDisclosure
FY 2025Yearly · 2025-12-31ProductKnees3,322,300,000USDDisclosure
FY 2025Yearly · 2025-12-31ProductSET2,150,200,000USDDisclosure
FY 2025Yearly · 2025-12-31ProductTechnology And Data Bone Cement And Surgical665,600,000USDDisclosure
Q3 2025Quarterly · 2025-09-30GeographyAmericas1,253,500,000USDDisclosure
Q3 2025Quarterly · 2025-09-30GeographyAsia Pacific330,900,000USDDisclosure
Q3 2025Quarterly · 2025-09-30GeographyEMEA417,000,000USDDisclosure
Q3 2025Quarterly · 2025-09-30ProductHips506,200,000USDDisclosure
Q3 2025Quarterly · 2025-09-30ProductKnees792,400,000USDDisclosure
Q3 2025Quarterly · 2025-09-30ProductSET541,500,000USDDisclosure
Q3 2025Quarterly · 2025-09-30ProductTechnology And Data Bone Cement And Surgical161,300,000USDDisclosure
Q2 2025Quarterly · 2025-06-30GeographyAmericas1,273,800,000USD0000950170-25-104989
Q2 2025Quarterly · 2025-06-30GeographyAsia Pacific336,100,000USD0000950170-25-104989
Q2 2025Quarterly · 2025-06-30GeographyEMEA467,500,000USD0000950170-25-104989
Q2 2025Quarterly · 2025-06-30ProductHips536,100,000USD0000950170-25-104989
Q2 2025Quarterly · 2025-06-30ProductKnees826,000,000USD0000950170-25-104989
Q2 2025Quarterly · 2025-06-30ProductSET550,600,000USD0000950170-25-104989
Q2 2025Quarterly · 2025-06-30ProductTechnology And Data Bone Cement And Surgical164,600,000USD0000950170-25-104989
Q4 2024Quarterly · 2024-12-31GeographyAmericas1,273,100,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31GeographyAsia Pacific312,500,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31GeographyEMEA437,700,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductHips519,900,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductKnees839,200,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductSET489,400,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductTechnology And Data Bone Cement And Surgical174,700,000USDLegacy provider
FY 2024Yearly · 2024-12-31GeographyAmericas4,794,800,000USDDisclosure
FY 2024Yearly · 2024-12-31GeographyAsia Pacific1,192,800,000USDDisclosure
FY 2024Yearly · 2024-12-31GeographyEMEA1,691,100,000USDDisclosure
FY 2024Yearly · 2024-12-31ProductHips1,999,100,000USDDisclosure
FY 2024Yearly · 2024-12-31ProductKnees3,173,500,000USDDisclosure
FY 2024Yearly · 2024-12-31ProductSET1,865,700,000USDDisclosure
FY 2024Yearly · 2024-12-31ProductTechnology And Data Bone Cement And Surgical640,300,000USDDisclosure
Q2 2024Quarterly · 2024-06-30GeographyAmericas1,199,300,000USD0000950170-25-104989
Q2 2024Quarterly · 2024-06-30GeographyAsia Pacific310,300,000USD0000950170-25-104989
Q2 2024Quarterly · 2024-06-30GeographyEMEA432,400,000USD0000950170-25-104989
Q2 2024Quarterly · 2024-06-30ProductHips506,500,000USD0000950170-25-104989
Q2 2024Quarterly · 2024-06-30ProductKnees801,100,000USD0000950170-25-104989
Q2 2024Quarterly · 2024-06-30ProductSET469,500,000USD0000950170-25-104989
Q2 2024Quarterly · 2024-06-30ProductTechnology And Data Bone Cement And Surgical164,900,000USD0000950170-25-104989
Q1 2024Quarterly · 2024-03-31GeographyAmericas1,186,500,000USD0000950170-25-063509
Q1 2024Quarterly · 2024-03-31GeographyAsia Pacific258,000,000USD0000950170-25-063509
Q1 2024Quarterly · 2024-03-31GeographyEMEA444,800,000USD0000950170-25-063509
Q1 2024Quarterly · 2024-03-31ProductHips491,200,000USD0000950170-25-063509
Q1 2024Quarterly · 2024-03-31ProductKnees788,100,000USD0000950170-25-063509
Q1 2024Quarterly · 2024-03-31ProductSET452,600,000USD0000950170-25-063509
Q1 2024Quarterly · 2024-03-31ProductTechnology And Data Bone Cement And Surgical157,300,000USD0000950170-25-063509
FY 2023Yearly · 2023-12-31GeographyAmericas4,624,100,000USDDisclosure
FY 2023Yearly · 2023-12-31GeographyAsia Pacific1,177,700,000USDDisclosure
FY 2023Yearly · 2023-12-31GeographyEMEA1,592,400,000USDDisclosure
FY 2023Yearly · 2023-12-31ProductHips1,967,200,000USDDisclosure
FY 2023Yearly · 2023-12-31ProductKnees3,038,400,000USDDisclosure
FY 2023Yearly · 2023-12-31ProductSET1,752,600,000USDDisclosure
FY 2023Yearly · 2023-12-31ProductTechnology And Data Bone Cement And Surgical636,000,000USDDisclosure
FY 2022Yearly · 2022-12-31GeographyAmericas4,295,500,000USD0000950170-25-026604
FY 2022Yearly · 2022-12-31GeographyAsia Pacific1,187,800,000USD0000950170-25-026604
FY 2022Yearly · 2022-12-31GeographyEMEA1,456,500,000USD0000950170-25-026604
FY 2022Yearly · 2022-12-31ProductHips1,894,900,000USD0000950170-25-026604
FY 2022Yearly · 2022-12-31ProductKnees2,778,300,000USD0000950170-25-026604
FY 2022Yearly · 2022-12-31ProductSET1,696,700,000USD0000950170-25-026604
FY 2022Yearly · 2022-12-31ProductTechnology And Data Bone Cement And Surgical570,000,000USD0000950170-25-026604
FY 2021Yearly · 2021-12-31GeographyAmericas4,102,100,000USD0000950170-24-019353
FY 2021Yearly · 2021-12-31GeographyAsia Pacific1,248,000,000USD0000950170-24-019353
FY 2021Yearly · 2021-12-31GeographyEMEA1,477,200,000USD0000950170-24-019353
FY 2021Yearly · 2021-12-31ProductHips1,856,100,000USD0000950170-24-019353
FY 2021Yearly · 2021-12-31ProductKnees2,647,900,000USD0000950170-24-019353
FY 2021Yearly · 2021-12-31ProductOther Product Category595,500,000USD0000950170-24-019353
FY 2021Yearly · 2021-12-31ProductSET1,727,800,000USD0000950170-24-019353
FY 2020Yearly · 2020-12-31GeographyAmericas3,699,500,000USD0000950170-23-004264
FY 2020Yearly · 2020-12-31GeographyAsia Pacific1,190,700,000USD0000950170-23-004264
FY 2020Yearly · 2020-12-31GeographyEMEA1,237,300,000USD0000950170-23-004264
FY 2020Yearly · 2020-12-31ProductHips1,750,500,000USD0000950170-23-004264
FY 2020Yearly · 2020-12-31ProductKnees2,378,300,000USD0000950170-23-004264
FY 2020Yearly · 2020-12-31ProductOther Product Category473,100,000USD0000950170-23-004264
FY 2020Yearly · 2020-12-31ProductSET1,525,600,000USD0000950170-23-004264
FY 2019Yearly · 2019-12-31GeographyAmericas4,875,800,000USD0001564590-22-007160
FY 2019Yearly · 2019-12-31GeographyAsia Pacific1,359,500,000USD0001564590-22-007160

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.